Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico A nationwide descriptive study

von García-Grimshaw, Miguel
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2021)